1,197
Participants
Start Date
February 28, 2007
Primary Completion Date
August 31, 2009
Study Completion Date
September 30, 2009
Rivaroxaban (Xarelto, BAY59-7939)
Patients randomized to rivaroxaban will receive rivaroxaban 20 mg once-daily.
Placebo
Patients allocated to placebo will receive a matching placebo tablet once daily.
Taoyuan District
Tainan City
Auckland
Bruxelles - Brussel
Vienna
Budapest
Quezon City
Budapest
Vienna
Bruxelles - Brussel
Genéve 14
Rud
Fredrikstad
Roodepoort
Sydney
Sydney
St Leonards
Johannesburg
Sydney
Kistarcsa
Johannesburg
Johannesburg
Johannesburg
Kogarah
Sydney
Gosford
Lismore
Lier
Duffel
Garran
Hellerup
Leuven
Box Hill
Melbourne
Clayton
Melbourne
Prahran
Geelong
Hasselt
Miskolc
Genk
Sint-Truiden
Brig
Liège
Redcliffe
Brisbane
Debrecen
Bruderholz
Woolloongabba
Southport
Nyíregyháza
Palmerston North
Namur
Adelaide
Salzburg
Adelaide
Yvoir
Perth
Kecskemét
Lucerne
Innsbruck
Wellington South
Fremantle
Szentes
Feldkirch
Worcester
Lugano
Chur
Somerset West
Cape Town
Cape Town
Aarhus C
Christchurch
Graz
Zurich
Brædstrup
Ghent
Zottegem
Szombathely
Taipei
Pathumwan, Bangkok
Bangkok
Jakarta
Bangkok
Berlin
Taipei
Berlin
Prague
Safed
Pittsburgh
Girona
Greifswald
Afula
Milan
Milan
Medan
Hamburg
Dijon
Fredericksburg
Pavia
Vernon
Kladno
Rotenburg (Wümme)
Greensboro
Greensboro
Madrid
Alcorcón
Fuenlabrada
Piacenza
Brest
Nîmes
Decatur
Venezia
Hanover
Pamplona
Haifa
Haifa
Toulouse
Melbourne
Bordeaux
Paderborn
Miami
Bay Pines
Castelnau-le-Lez
Montpellier
Haifa
Padua
Giessen
Tours
Grenoble
Grenoble
Magdeburg
Bologna
Bandung
Düsseldorf
Saint-Etienne
Roanne
Parma
Nantes
Kfar Saba
Essen
Xàtiva
Agen
Angers
Petah Tikva
Semarang
Vandœuvre-lès-Nancy
Mainz
Holon
Witten
Lille
Valenciennes
Soest
Seinäjoki
Frankfurt am Main
Arras
Clermont-Ferrand
Tel Aviv
Darmstadt
Orthez
Wiesbaden
Brno
Chieti
Homburg
Homburg
Strasbourg
Kuala Selangor
Mannheim
Heidelberg
Neckargemünd
Pierre-Bénite
Covington
Tübingen
Little Rock
Oklahoma City
Paris
Corsicana
Paris
Paris
Paris
Rouen
Rehovot
Karlsbad
Bruchsal
San Antonio
Ashkelon
Amiens
Napoli
München
Kaohsiung City
München
Toulon
Idaho Falls
Beersheba
Murray
Salt Lake City
Augsburg
Limoges
Albuquerque
Los Angeles
Palermo
Jerusalem
Clamart
Redlands
Colombes
Créteil
Würzburg
Spokane
Beijing
Beijing
Beijing
Beijing
Beijing
Beijing
Beijing
Shenyang
New Delhi
Harbin
Singapore
Shanghai
Shanghai
Shanghai
Suzhou
Singapore
Mumbai
Mumbai
Mumbai
Pune
Wuhan
Hyderabad
Guangzhou
Vellore
Kochi
Kolkata
Daegu
Londrina
Miami
Baltimore
Boston
Chapel Hill
Burlington
Uberaba
Curitiba
Porto Alegre
Rio de Janeiro
Hong Kong
London
Botucatu
São Paulo
São Paulo
São Paulo
São Paulo
Sorocaba
Winnipeg
Toronto
Karlovy Vary
Ostrava
Ostrava-Poruba
Prague
Prague
Prague
Usti Nad Lebem
Frederiksberg
Dresden
Leipzig
Halle
's-Hertogenbosch
Amsterdam
Arnhem
Dordrecht
Enschede
Groningen
Hoofddorp
Maastricht
Rotterdam
Zwijndrecht
Zwolle
Auckland
Oslo
Oslo
Quezon City
Bialystok
Bydgoszcz
Gdansk
Katowice
Krakow
Lodz
Lublin
Poznan
Poznan
Torun
Warsaw
Warsaw
Warsaw
Wroclaw
Wroclaw
Pretoria
Pretoria
Pretoria
Seoul
Daegu
Seoul
Seoul
Taegu
Barcelona
Barcelona
Terrassa
Borås
Gothenburg
Gothenburg
Jönköping
Sundsvall
Västervik
Plymouth
Chelmsford
Romford
Isleworth
London
London
Edinburgh
Liverpool
London
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
Bayer
INDUSTRY